Enhancing the Value of Population-Based Risk Scores for Institutional-Level Use

被引:3
|
作者
Raza, Sajjad
Sabik, Joseph F., III
Rajeswaran, Jeevanantham
Idrees, Jay J.
Trezzi, Matteo
Riaz, Haris
Javadikasgari, Hoda
Nowicki, Edward R.
Svensson, Lars G.
Blackstone, Eugene H.
机构
[1] Cleveland Clin, Dept Thorac & Cardiovasc Surg, Inst Heart & Vasc, Dept Quantitat Hlth Sci,Res Inst, Cleveland, OH 44195 USA
[2] Cleveland Clin, Dept Internal Med, Inst Med, Cleveland, OH 44195 USA
来源
ANNALS OF THORACIC SURGERY | 2016年 / 102卷 / 01期
关键词
AORTIC-VALVE-REPLACEMENT; CARDIAC-SURGERY; SURGICAL RISK; MORTALITY; MODELS; MORBIDITY; OUTCOMES; SOCIETY; REOPERATION; TRANSFUSION;
D O I
10.1016/j.athoracsur.2015.12.055
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. We hypothesized that factors associated with an institution's residual risk unaccounted for by population-based models may be identifiable and used to enhance the value of population-based risk scores for quality improvement. Methods. From January 2000 to January 2010, 4,971 patients underwent aortic valve replacement (AVR), either isolated (n = 2,660) or with concomitant coronary artery bypass grafting (AVR+CABG; n = 2,311). Operative mortality and major morbidity and mortality predicted by The Society of Thoracic Surgeons (STS) risk models were compared with observed values. After adjusting for patients' STS score, additional and refined risk factors were sought to explain residual risk. Differences between STS model coefficients (risk-factor strength) and those specific to our institution were calculated. Results. Observed operative mortality was less than predicted for AVR (1.6% [42 of 2,660] vs 2.8%, p < 0.0001) and AVR+CABG (2.6% [59 of 2,311] vs 4.9%, p < 0.0001). Observed major morbidity and mortality was also lower than predicted for isolated AVR (14.6% [389 of 2,660] vs 17.5%, p < 0.0001) and AVR+CABG (20.0% [462 of 2,311] vs 25.8%, p < 0.0001). Shorter height, higher bilirubin, and lower albumin were identified as additional institution-specific risk factors, and body surface area, creatinine, glomerular filtration rate, blood urea nitrogen, and heart failure across all levels of functional class were identified as refined risk-factor variables associated with residual risk. In many instances, risk-factor strength differed substantially from that of STS models. Conclusions. Scores derived from population-based models can be enhanced for institutional level use by adjusting for institution-specific additional and refined risk factors. Identifying these and measuring differences in institution-specific versus population-based risk-factor strength can identify areas to target for quality improvement initiatives. (C) 2016 by The Society of Thoracic Surgeons
引用
收藏
页码:70 / 77
页数:8
相关论文
共 50 条
  • [31] A comparative assessment between Globorisk and WHO cardiovascular disease risk scores: a population-based study
    Dehghan, Azizallah
    Rezaei, Fatemeh
    Aune, Dagfinn
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [32] THE ASSOCIATION BETWEEN POLYGENIC RISK SCORES AND TRANSDIAGNOSTIC VULNERABILITY TRAITS IN A POPULATION-BASED YOUTH SAMPLE
    Aicoboaie, Stefana
    Pappaianni, Edoardo
    Abdulkadir, Mohamed
    Micali, Nadia
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2023, 75 : S175 - S176
  • [33] Predicting hepatic encephalopathy in patients with cirrhosis: A UK population-based study and validation of risk scores
    Jones, Bethan I.
    Jenkins, Cerys A.
    Murphy, Daniel
    Orr, James
    Yeoman, Andrew
    Hubbuck, Ellen R.
    Heywood, Ben R.
    Currie, Craig J.
    HEPATOLOGY COMMUNICATIONS, 2023, 7 (11) : e0307
  • [34] Use of Insulin and the Risk of Progression of Pancreatitis: A Population-Based Cohort Study
    Cho, Jaelim
    Scragg, Robert
    Petrov, Maxim S.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 107 (03) : 580 - 587
  • [35] Triptan Use as a Function of Cardiovascular Risk. A Population-Based Study
    Bigal, Marcelo
    Golden, Wendy
    Buse, Dawn
    Chen, Ya-Ting
    Lipton, Richard
    NEUROLOGY, 2010, 74 (09) : A582 - A582
  • [36] Antidepressant use and risk of adverse outcomes: population-based cohort study
    Coupland, Carol
    Dhiman, Paula
    Morriss, Richard
    Arthur, Antony
    Barton, Garry
    Hippisley-Cox, Julia
    BJPSYCH OPEN, 2022, 8 (05):
  • [37] Statin use and risk of glioma: population-based case–control analysis
    Corinna Seliger
    Christoph Rudolf Meier
    Claudia Becker
    Susan Sara Jick
    Ulrich Bogdahn
    Peter Hau
    Michael Fred Leitzmann
    European Journal of Epidemiology, 2016, 31 : 947 - 952
  • [38] STATIN USE AND THE RISK OF COLORECTAL CANCER: A POPULATION-BASED COHORT STUDY
    Ceccarelli, M.
    Maio, V
    Slabaugh, S. L.
    Rabinowitz, C.
    Diamond, J. J.
    VALUE IN HEALTH, 2010, 13 (03) : A26 - A26
  • [39] Population-based cohort study of oral contraceptive use and risk of depression
    Johansson, T.
    Larsen, S. Vinther
    Bui, M.
    Ek, W. E.
    Karlsson, T.
    Johansson, A.
    EPIDEMIOLOGY AND PSYCHIATRIC SCIENCES, 2023, 32
  • [40] Benzodiazepine Use and Risk of Dementia: A Prospective Population-Based Cohort Study
    de Gage, Sophie Billioti
    Begaud, Bernard
    Bazin, Fabienne
    Verdoux, Helene
    Dartigues, Jean-Francois
    Peres, Karine
    Kurth, Tobias
    Pariente, Antoine
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 422 - 422